Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1995 Feb;54(2):155–156. doi: 10.1136/ard.54.2.155-b

Secondary acute myeloid leukaemia with 7q- complicating azathioprine treatment for rheumatoid arthritis.

C C Mok, Y L Kwong, C S Lau
PMCID: PMC1005544  PMID: 7702408

Full text

PDF
155

Images in this article

155Image
on p.155
156Image
on p.156

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A., Gralnick H. R., Sultan C. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med. 1985 Oct;103(4):620–625. doi: 10.7326/0003-4819-103-4-620. [DOI] [PubMed] [Google Scholar]
  2. Golomb H. M., Alimena G., Rowley J. D., Vardiman J. W., Testa J. R., Sovik C. Correlation of occupation and karyotype in adults with acute nonlymphocytic leukemia. Blood. 1982 Aug;60(2):404–411. [PubMed] [Google Scholar]
  3. Isomäki H. A., Hakulinen T., Joutsenlahti U. Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritis. J Chronic Dis. 1978;31(11):691–696. doi: 10.1016/0021-9681(78)90071-1. [DOI] [PubMed] [Google Scholar]
  4. Isomäki H. A., Mutru O., Koota K. Death rate and causes of death in patients with rheumatoid arthritis. Scand J Rheumatol. 1975;4(4):205–208. doi: 10.3109/03009747509165257. [DOI] [PubMed] [Google Scholar]
  5. Johansson B., Mertens F., Mitelman F. Cytogenetic deletion maps of hematologic neoplasms: circumstantial evidence for tumor suppressor loci. Genes Chromosomes Cancer. 1993 Dec;8(4):205–218. doi: 10.1002/gcc.2870080402. [DOI] [PubMed] [Google Scholar]
  6. Kwong Y. L., Wong K. F., Chan T. K. Toxic exposures and haematological disorders. Br J Haematol. 1994 Jun;87(2):442–443. doi: 10.1111/j.1365-2141.1994.tb04944.x. [DOI] [PubMed] [Google Scholar]
  7. Le Beau M. M., Albain K. S., Larson R. A., Vardiman J. W., Davis E. M., Blough R. R., Golomb H. M., Rowley J. D. Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7. J Clin Oncol. 1986 Mar;4(3):325–345. doi: 10.1200/JCO.1986.4.3.325. [DOI] [PubMed] [Google Scholar]
  8. Matteson E. L., Hickey A. R., Maguire L., Tilson H. H., Urowitz M. B. Occurrence of neoplasia in patients with rheumatoid arthritis enrolled in a DMARD Registry. Rheumatoid Arthritis Azathioprine Registry Steering Committee. J Rheumatol. 1991 Jun;18(6):809–814. [PubMed] [Google Scholar]
  9. Mitelman F., Brandt L., Nilsson P. G. Relation among occupational exposure to potential mutagenic/carcinogenic agents, clinical findings, and bone marrow chromosomes in acute nonlymphocytic leukemia. Blood. 1978 Dec;52(6):1229–1237. [PubMed] [Google Scholar]
  10. Pedersen-Bjergaard J., Philip P. Cytogenetic characteristics of therapy-related acute nonlymphocytic leukaemia, preleukaemia and acute myeloproliferative syndrome: correlation with clinical data for 61 consecutive cases. Br J Haematol. 1987 Jun;66(2):199–207. doi: 10.1111/j.1365-2141.1987.tb01299.x. [DOI] [PubMed] [Google Scholar]
  11. Vasquez S., Kavanaugh A. F., Schneider N. R., Wacholtz M. C., Lipsky P. E. Acute nonlymphocytic leukemia after treatment of systemic lupus erythematosus with immunosuppressive agents. J Rheumatol. 1992 Oct;19(10):1625–1627. [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES